Eli Lilly and Company LLY
1,183.46
1.57
0.13%
as of 25 Sep
- Market cap
- $1.11T
- P/E
- 39.7×
Follow LLY
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Eli Lilly and Company (LLY) Operating margin
Eli Lilly and Company's operating margin over the twelve months to 30 June 2026 was 42.2%, up 1.9 percentage points from fiscal 2025 (40.4%). Over the past ten years it has ranged from 10.0% (fiscal 2017) to 40.4% (fiscal 2025) — the current reading is the highest in ten years. That is above the Drug Manufacturers General industry median of 18.9% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Annual
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 40.4% | 11.71 |
| FY2024 | 28.6% | 9.72 |
| FY2023 | 18.9% | (6.05) |
| FY2022 | 25.0% | 2.52 |
| FY2021 | 22.5% | (2.24) |
| FY2020 | 24.7% | 2.40 |
| FY2019 | 22.3% | 5.85 |
| FY2018 | 16.4% | 6.41 |
| FY2017 | 10.0% | (5.34) |
| FY2016 | 15.4% | 1.90 |
Quarterly
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | 39.1% | (5.95) |
| Mar 2026 | 45.0% | 1.62 |
| Dec 2025 | 43.4% | 1.56 |
| Sep 2025 | 41.9% | (2.29) |
| 42 more quarters | Free account |
Against its own ten years
Low 10.0%
High 40.4%
Ten-year median
22.3%
Current reading's percentile
100
Operating margin against peers
| Company | Operating margin |
|---|---|
| LLY Eli Lilly and Company | 42.2% |
| NVS Novartis AG compare | 30.2% |
| AMGN Amgen Inc. compare | 30.0% |
| JNJ Johnson & Johnson compare | 27.7% |
| ABBV AbbVie Inc. compare | 26.2% |
| AZN AstraZeneca PLC compare | 22.8% |
| PFE Pfizer Inc. compare | 21.7% |
| MRK Merck & Co., Inc. compare | 10.5% |
| GILD Gilead Sciences, Inc. compare | −8.20% |
| Drug Manufacturers General industry median | 18.9% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on LLY
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement